menu
    • menu

    Company profile for Cambrex Corporation

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years of API development and manufacturing expertise, a growing team of more than 1,200 experts and a strong presence in the USA and Europe, we are tried and trusted across branded and generic API markets. We put all of our energy and experience into bein...
    Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. With over 35 years of API development and manufacturing expertise, a growing team of more than 1,200 experts and a strong presence in the USA and Europe, we are tried and trusted across branded and generic API markets. We put all of our energy and experience into being your partner of choice. We create value for customers through manufacturing excellence, reliable quality and innovative science. Our people are the experts that our customers enjoy working with.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cambrex CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Meadowlands Plaza, East Rutherford, NJ 07073
    Telephone
    Telephone
    +1 201-804-3000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cambrex.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/13418/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cambrex

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI China

    Not Confirmed

    envelop Contact Supplier

    CPhI China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 1208

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaProviding RSMs & API to Global Pharma CompaniesProviding RSMs & API to Global Pharma Companies

    Providing RSMs & API to Global Pharma Companies
    Providing RSMs & API to Global Pharma Companies

    reelProviding RSMs & API to Global Pharma Companies

    This PharmaReel showcases Allsino Pharmaceutical, a company that provides GMP-certified RSMs and APIs to global pharma companies, specializing in peptides, oligonucleotides, and small molecule CDMO services. Allsino has a presence in the US, EU, China and Japan.

    Impressions: 834

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    The pharmaceutical industry has witnessed a wave of mergers, acquisitions, and strategic partnerships so far in the first half (H1) of 2025, with deal values exceeding US$ 170 billion.PharmaCompass’ data shows oncology alone accounted for nearly US$ 47 billion in deal value, followed by US$ 18 billion each in immunology and psychiatry, US$ 17 billion in nutrition/weight loss and US$ 7 billion in neurology.Pharma majors such as Johnson & Johnson and Bristol Myers Squibb led with two deals worth over US$ 10 billion each. Sanofi executed a series of deals in the immunology and neuro-inflammation space. And Eli Lilly stood out for its aggressive dealmaking, which spanned oncology, pain, RNA therapies, and AI-driven oligonucleotides. In all, it signed seven deals worth over US$ 1 billion each. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available)H1 records several mega deals as J&J buys Intra-Cellular, BMS ties up with BioNTech, Sanofi acquires BlueprintJohnson & Johnson dominated headlines with its US$ 14.6 billion acquisition of Intra-Cellular Therapies in January 2025. This marks the largest biopharma deal since Novo Nordisk’s US$ 16.5 billion acquisition of Catalent in February 2024. This acquisition positions J&J as a formidable player in the neuroscience space. Bristol Myers Squibb entered into a US$ 11.1 billion partnership with BioNTech. The deal structure — US$ 3.5 billion in unconditional payments and up to US$ 7.6 billion in milestone payments — demonstrates BMS’ confidence in BNT327, a next-generation bispecific antibody in phase 3 trials for treating extensive stage small cell lung cancer and non-small cell lung cancer.Sanofi acquired Blueprint Medicines for US$ 9.5 billion in order to enhance its rare disease portfolio. The French drugmaker is also creating a comprehensive immunology portfolio. The company signed a US$ 1.9 billion deal for Dren Bio’s DR-0201 bispecific antibody for autoimmune diseases. Sanofi also acquired Vigil Neuroscience for US$ 470 million for its phase 2-ready Alzheimer’s disease candidate. Additionally, the drugmaker secured a US$ 1.84 billion global license agreement with Earendil Labs for two next-generation bispecific antibodies.Pfizer’s US$ 6.05 billion partnership with 3SBio provides it global licensing rights (excluding China) for SSGJ-707, a bispecific antibody currently undergoing multiple clinical trials in China for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Obesity gold rush sees Roche, AbbVie, Sciwind ink deals; Novo pledges over US$ 5 bn across three dealsThe obesity therapeutics market has triggered intense competition among pharmaceutical giants. Roche’s US$ 5.3 billion partnership with Zealand Pharma is focused on petrelintide, an amylin analog designed to preserve lean mass better than existing GLP-1-based treatments. The collaboration combines petrelintide with Roche’s dual GLP-1/GIP receptor agonist CT-388, creating a differentiated obesity treatment.Market leader Novo Nordisk has promised over US$ 5 billion across three major obesity deals in 2025. The US$ 2.2 billion Septerna collaboration targets oral small molecule medicines for obesity and cardiometabolic diseases.Novo signed a separate US$ 2 billion agreement with China’s United Biotechnology for UBT251, a triple agonist for GLP-1, GIP, and glucagon receptors in phase 2 clinical development for obesity, type 2 diabetes, and other diseases. The company’s third major deal, a US$ 1 billion partnership with Lexicon Pharmaceuticals, provides it access to LX9851, a molecule in preclinical development for obesity and associated metabolic disorders.Sciwind Biosciences secured a US$ 2.5 billion global licensing and collaboration agreement with Verdiva Bio Limited for the global development and commercialization of a portfolio of metabolic diseases therapies. AbbVie entered the amylin arena through its US$ 2.2 billion Gubra partnership for GUB014295, a candidate in phase 1 trials for treating obesity. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Molecular glue degraders draw investments; Lilly signs seven deals over US$ 1 billion eachMolecular glue degraders have emerged as a transformative therapeutic modality, attracting significant investment across multiple partnerships. AbbVie’s US$ 1.64 billion collaboration with Neomorph leverages the biotech’s leading molecular glue discovery platform for oncology and immunology applications.Genentech’s potential US$ 2.1 billion partnership with Orionis Biosciences focuses on small-molecule monovalent glue medicines for novel and challenging oncology targets. This is the second partnership between the two companies, following their initial 2023 collaboration.Eli Lilly has collaborated with Magnet Biomedicine, utilizing Magnet’s TrueGlue discovery platform for oncology applications. The deal could be worth up to US$ 1.3 billion.Eli Lilly has emerged as one of 2025’s most active dealmakers, with approximately seven deals exceeding US$ 1 billion each. The company’s US$ 2.5 billion Scorpion Therapeutics acquisition provides access to STX-478, an experimental oral therapy in early-stage trials for breast cancer and advanced solid tumors, potentially addressing 30 to 40 percent of hormone-positive breast cancer patients.On June 17, Lilly announced the acquisition of gene-editing startup Verve Therapeutics for US$ 1.3 billion. Lilly’s US$ 1 billion SiteOne acquisition announced in May brings STC-004, a phase 2-ready non-opioid chronic pain treatment to its pipeline. Other partnerships announced by Lilly include a US$ 1.4 billion capsid licensing deal with Sangamo for central nervous system disease genomic medicines and a US$ 1.3 billion collaboration with South Korean company Rznomics for RNA-based hearing loss treatments. Lilly has also strengthened its oligonucleotide pipeline through a potential US$ 1 billion collaboration with Creyon Bio for AI-designed oligonucleotide therapies targeting RNA. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Merck KGaA acquires SpringWorks for US$ 3.9 bn; Novartis buys out Anthos for US$ 3.1 bnAstraZeneca signed a US$ 5.3 billion AI-led research agreement with China’s CSPC Pharmaceuticals Group to advance the discovery of novel oral candidates for immunological diseases. Merck KGaA acquired SpringWorks for US$ 3.9 billion in April, which gave it access to two FDA-approved therapies — Ogsiveo (nirogacestat), the first and only approved therapy for adult patients with progressing desmoid tumors requiring systemic treatment, and Gomekli (mirdametinib), the first and only FDA-approved therapy for adults and children with neurofibromatosis type 1-associated plexiform neurofibromas.Novartis’ US$ 3.1 billion Anthos Therapeutics acquisition centered around abelacimab, a potential first-in-class monoclonal antibody currently in three phase 3 studies for stroke and systemic embolism prevention in atrial fibrillation patients.GSK’s US$ 2 billion acquisition of Boston Pharmaceuticals’ efimosfermin targets steatotic liver disease (fatty liver disease). The medicine is also in clinical development for MASH treatment. GSK’s second major deal involved the US$ 1.15 billion acquisition of US biotech IDRx, strengthening its gastrointestinal cancer portfolio.The pharma industry also drew some private equity interest as Bain Capital acquired Japan’s Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group for US$ 3.3 billion. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Our viewDespite an uncertain geopolitical environment, the year has seen a surge in M&As and dealmaking in the first half of 2025. However, a sizable chunk of the acquisitions were bolt-on transactions, indicating that companies are not ready to take on risks, and are buying out smaller players who strategically fit into their operations. Going forward, there are indications that M&A activity will stay strong throughout 2025. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2461

    https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025

    #PharmaFlow by PHARMACOMPASS
    19 Jun 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Cambrex Partners with Lilly to Support Biotech Manufacturing
    Cambrex Partners with Lilly to Support Biotech Manufacturing

    05 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cambrex-announces-strategic-agreement-with-lilly-to-support-biotech-collaborator-manufacturing-302323176.html

    PR NEWSWIRE
    05 Dec 2024
    Share Share
    Cambrex Opens New Stability Storage Facility In North Carolina
    Cambrex Opens New Stability Storage Facility In North Carolina

    17 Oct 2024

    // PRESS RELEASE

    https://www.cambrex.com/news/cambrex-opens-new-stability-storage-facility-in-durham-north-carolina/

    PRESS RELEASE
    17 Oct 2024
    Share Share
    Atinary Tech Announces Collaboration with Snapdragon Chemistry
    Atinary Tech Announces Collaboration with Snapdragon Chemistry

    26 Sep 2024

    // PRESS RELEASE

    https://www.cambrex.com/news/atinary-technologies-announces-strategic-collaboration-with-snapdragon-chemistry-a-cambrex-company/

    PRESS RELEASE
    26 Sep 2024
    Share Share
    Cambrex Announces New Liquid-Phase Peptide Synthesis Technology
    Cambrex Announces New Liquid-Phase Peptide Synthesis Technology

    19 Sep 2024

    // PRESS RELEASE

    https://www.cambrex.com/news/cambrex-announces-new-liquid-phase-peptide-synthesis-manufacturing-technology/

    PRESS RELEASE
    19 Sep 2024
    Share Share
    Cambrex Expands Stability Storage With New Facility In Durham, North Carolina
    Cambrex Expands Stability Storage With New Facility In Durham, North Carolina

    08 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cambrex-to-expand-stability-storage-business-with-new-facility-in-durham-north-carolina-302190242.html

    PR NEWSWIRE
    08 Jul 2024
    Share Share
    Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan
    Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan

    18 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cambrex-nears-completion-of-5-year-100-million-dollar-investment-plan-one-year-ahead-of-schedule-302090916.html

    PR NEWSWIRE
    18 Mar 2024
    Share Share

    Services

    Upload your portfolio for free, ask us

    Analytical

    Click here to discover the service providers for Analytical

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Packaging

    Click here to discover the service providers for Packaging

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Cambrex Corporation and get a quotation

    Cambrex Corporation is a supplier offers 189 products (APIs, Excipients or Intermediates).

    Find a price of Alprazolam bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Amiodarone Hydrochloride bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Bupivacaine Hydrochloride bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Epinephrine bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Fentanyl bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Hydrochlorothiazide bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Lidocaine bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Lidocaine Hydrochloride bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Lorazepam bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Mesalazine bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Midazolam bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Ondansetron Hydrochloride bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Rivastigmine bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Sodium Cromoglicate bulk with DMF, CEP, JDMF offered by Cambrex Corporation

    Find a price of Amphetamine Sulfate bulk with DMF, CEP offered by Cambrex Corporation

    Find a price of Aripiprazole bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Benzoyl Peroxide bulk with DMF, CEP offered by Cambrex Corporation

    Find a price of Bisacodyl bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Chlordiazepoxide bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Clorazepate Dipotassium bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Clozapine bulk with DMF, CEP offered by Cambrex Corporation

    Find a price of Cysteamine Bitartrate bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Diazepam bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Epinephrine Bitartrate bulk with DMF, CEP offered by Cambrex Corporation

    Find a price of Estazolam bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Fentanyl Citrate bulk with DMF, CEP offered by Cambrex Corporation

    Find a price of Glibenclamide bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Lacosamide bulk with DMF, CEP offered by Cambrex Corporation

    Find a price of Lormetazepam bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Mesalazine bulk with DMF, CEP offered by Cambrex Corporation

    Find a price of Nicotine bulk with DMF, CEP offered by Cambrex Corporation

    Find a price of Norepinephrine Bitartrate bulk with DMF, CEP offered by Cambrex Corporation

    Find a price of Raloxifene Hydrochloride bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Rifaximin bulk with DMF, CEP offered by Cambrex Corporation

    Find a price of Salbutamol Sulphate bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Sodium Picosulfate bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Sotalol Hydrochloride bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Sulfasalazine bulk with CEP, JDMF offered by Cambrex Corporation

    Find a price of Torsemide bulk with DMF, CEP offered by Cambrex Corporation

    Find a price of Triazolam bulk with DMF, JDMF offered by Cambrex Corporation

    Find a price of Zolpidem Tartrate bulk with DMF, CEP offered by Cambrex Corporation

    Find a price of Ofloxacin bulk with DMF offered by Cambrex Corporation

    Find a price of Ambroxol Hydrochloride bulk with JDMF offered by Cambrex Corporation

    Find a price of Amiloride Hydrochloride bulk with DMF offered by Cambrex Corporation

    Find a price of Amphetamine Aspartate bulk with DMF offered by Cambrex Corporation

    Find a price of Amphetamine Sulfate bulk with DMF offered by Cambrex Corporation

    Find a price of Bromazepam bulk with CEP offered by Cambrex Corporation

    Find a price of Brotizolam bulk with JDMF offered by Cambrex Corporation

    Find a price of Bupivacaine bulk with DMF offered by Cambrex Corporation

    Find a price of Buprenorphine Hydrochloride bulk with DMF offered by Cambrex Corporation

    Find a price of Calcium Oxybate bulk with DMF offered by Cambrex Corporation

    Find a price of Chlordiazepoxide bulk with DMF offered by Cambrex Corporation

    Find a price of Chlorothiazide bulk with DMF offered by Cambrex Corporation

    Find a price of Clobazam bulk with DMF offered by Cambrex Corporation

    Find a price of Clonazepam bulk with DMF offered by Cambrex Corporation

    Find a price of Cysteamine Bitartrate bulk with DMF offered by Cambrex Corporation

    Find a price of Dextroamphetamine Saccharate bulk with DMF offered by Cambrex Corporation

    Find a price of Diclofenac Epolamine bulk with DMF offered by Cambrex Corporation

    Find a price of Diltiazem Hydrochloride bulk with DMF offered by Cambrex Corporation

    Find a price of Eltrombopag bulk with DMF offered by Cambrex Corporation

    Find a price of Erlotinib Hydrochloride bulk with DMF offered by Cambrex Corporation

    Find a price of Erythromycin Lactobionate bulk with JDMF offered by Cambrex Corporation

    Find a price of Etizolam bulk with JDMF offered by Cambrex Corporation

    Find a price of Flunitrazepam bulk with JDMF offered by Cambrex Corporation

    Find a price of Flurazepam bulk with DMF offered by Cambrex Corporation

    Find a price of Glipizide bulk with DMF offered by Cambrex Corporation

    Find a price of Hydrocodone Bitartrate bulk with DMF offered by Cambrex Corporation

    Find a price of Labetalol Hydrochloride bulk with DMF offered by Cambrex Corporation

    Find a price of Lapatinib Ditosylate bulk with DMF offered by Cambrex Corporation

    Find a price of Magnesium Oxybate bulk with DMF offered by Cambrex Corporation

    Find a price of Maraviroc bulk with DMF offered by Cambrex Corporation

    Find a price of Medazepam bulk with JDMF offered by Cambrex Corporation

    Find a price of Metaproterenol Hemisulfate bulk with DMF offered by Cambrex Corporation

    Find a price of Methyclothiazide bulk with DMF offered by Cambrex Corporation

    Find a price of Methylphenidate Hydrochloride bulk with DMF offered by Cambrex Corporation

    Find a price of Midazolam Hydrochloride bulk with DMF offered by Cambrex Corporation

    Find a price of Midazolam Maleate bulk with DMF offered by Cambrex Corporation

    Find a price of Norepinephrine Bitartrate bulk with CEP offered by Cambrex Corporation

    Find a price of Olaparib bulk with DMF offered by Cambrex Corporation

    Find a price of Opium bulk with DMF offered by Cambrex Corporation

    Find a price of Ospemifene bulk with DMF offered by Cambrex Corporation

    Find a price of Oxazepam bulk with DMF offered by Cambrex Corporation

    Find a price of Pirfenidone bulk with CEP offered by Cambrex Corporation

    Find a price of Potassium Oxybate bulk with DMF offered by Cambrex Corporation

    Find a price of Rivaroxaban bulk with CEP offered by Cambrex Corporation

    Find a price of Rivastigmine Tartrate bulk with CEP offered by Cambrex Corporation

    Find a price of Sodium Oxybate bulk with DMF offered by Cambrex Corporation

    Find a price of Sulfapyridine bulk with DMF offered by Cambrex Corporation

    Find a price of Temazepam bulk with DMF offered by Cambrex Corporation

    Find a price of Teprenone bulk with JDMF offered by Cambrex Corporation

    Find a price of Terbutaline Sulfate bulk with DMF offered by Cambrex Corporation

    Find a price of Acebutolol Hydrochloride bulk offered by Cambrex Corporation

    Find a price of Acetazolamide bulk offered by Cambrex Corporation

    Find a price of Acetohexamide bulk offered by Cambrex Corporation

    Find a price of Amoxapine bulk offered by Cambrex Corporation

    Find a price of Butalbital bulk offered by Cambrex Corporation

    Find a price of Carvedilol bulk offered by Cambrex Corporation

    Find a price of Cetirizine Dihydrochloride bulk offered by Cambrex Corporation

    Find a price of Cinoxacin bulk offered by Cambrex Corporation

    Find a price of Dextromethorphan bulk offered by Cambrex Corporation

    Find a price of Dextropropoxyphene bulk offered by Cambrex Corporation

    Find a price of Diclofenac Potassium bulk offered by Cambrex Corporation

    Find a price of Diflunisal bulk offered by Cambrex Corporation

    Find a price of Econazole Nitrate bulk offered by Cambrex Corporation

    Find a price of Fenoprofen Calcium bulk offered by Cambrex Corporation

    Find a price of Fentanyl Citrate bulk offered by Cambrex Corporation

    Find a price of Isosorbide Mononitrate bulk offered by Cambrex Corporation

    Find a price of Lamotrigine bulk offered by Cambrex Corporation

    Find a price of Levetiracetam bulk offered by Cambrex Corporation

    Find a price of Lisdexamfetamine Dimesylate bulk offered by Cambrex Corporation

    Find a price of Meclofenamic Acid bulk offered by Cambrex Corporation

    Find a price of Metoprolol Tartrate bulk offered by Cambrex Corporation

    Find a price of Naproxen bulk offered by Cambrex Corporation

    Find a price of Naproxen Sodium bulk offered by Cambrex Corporation

    Find a price of Nitazoxanide bulk offered by Cambrex Corporation

    Find a price of Nitrofurantoin bulk offered by Cambrex Corporation

    Find a price of Phentermine Hydrochloride bulk offered by Cambrex Corporation

    Find a price of Phenylephrine Hydrochloride bulk offered by Cambrex Corporation

    Find a price of Propafenone Hydrochloride bulk offered by Cambrex Corporation

    Find a price of Propoxyphene Napsylate bulk offered by Cambrex Corporation

    Find a price of Quetiapine Hemifumarate bulk offered by Cambrex Corporation

    Find a price of Salbutamol Sulphate bulk offered by Cambrex Corporation

    Find a price of Sufentanil Citrate bulk offered by Cambrex Corporation

    Find a price of SGD-1910 bulk offered by Cambrex Corporation

    Find a price of 4-Aminobenzoic Acid bulk offered by Cambrex Corporation

    Find a price of Acoramidis Hydrochloride bulk offered by Cambrex Corporation

    Find a price of Aficamten bulk offered by Cambrex Corporation

    Find a price of Amphetamine Aspartate bulk offered by Cambrex Corporation

    Find a price of Amphetamine Sulfate bulk offered by Cambrex Corporation

    Find a price of Aripiprazole bulk offered by Cambrex Corporation

    Find a price of Aripiprazole Lauroxil bulk offered by Cambrex Corporation

    Find a price of Berotralstat Hydrochloride bulk offered by Cambrex Corporation

    Find a price of Camizestrant bulk offered by Cambrex Corporation

    Find a price of Capromorelin bulk offered by Cambrex Corporation

    Find a price of Carprofen bulk offered by Cambrex Corporation

    Find a price of Chlordiazepoxide HCl bulk offered by Cambrex Corporation

    Find a price of Chlormadinone Acetate bulk offered by Cambrex Corporation

    Find a price of Chlorpheniramine bulk offered by Cambrex Corporation

    Find a price of CLN-081 bulk offered by Cambrex Corporation

    Find a price of Danicopan bulk offered by Cambrex Corporation

    Find a price of Dextroamphetamine Saccharate bulk offered by Cambrex Corporation

    Find a price of Dronedarone Hydrochloride bulk offered by Cambrex Corporation

    Find a price of Eletriptan Hydrobromide bulk offered by Cambrex Corporation

    Find a price of Emtricitabine bulk offered by Cambrex Corporation

    Find a price of Ensitrelvir bulk offered by Cambrex Corporation

    Find a price of Erlotinib Hydrochloride bulk offered by Cambrex Corporation

    Find a price of Fentanyl bulk offered by Cambrex Corporation

    Find a price of Ferric Maltol bulk offered by Cambrex Corporation

    Find a price of Ferric Pyrophosphate Citrate bulk offered by Cambrex Corporation

    Find a price of Filgotinib bulk offered by Cambrex Corporation

    Find a price of Flibanserin bulk offered by Cambrex Corporation

    Find a price of Flurazepam Dihydrochloride bulk offered by Cambrex Corporation

    Find a price of Furosemide bulk offered by Cambrex Corporation

    Find a price of Hydrocodone Bitartrate bulk offered by Cambrex Corporation

    Find a price of Hydromorphone Hydrochloride bulk offered by Cambrex Corporation

    Find a price of Idelalisib bulk offered by Cambrex Corporation

    Find a price of Lenalidomide bulk offered by Cambrex Corporation

    Find a price of Lifitegrast bulk offered by Cambrex Corporation

    Find a price of Linagliptin bulk offered by Cambrex Corporation

    Find a price of Methylphenidate bulk offered by Cambrex Corporation

    Find a price of Methylphenidate Hydrochloride bulk offered by Cambrex Corporation

    Find a price of Momelotinib bulk offered by Cambrex Corporation

    Find a price of Naloxegol Oxalate bulk offered by Cambrex Corporation

    Find a price of Nicotine bulk offered by Cambrex Corporation

    Find a price of Nitroglycerin bulk offered by Cambrex Corporation

    Find a price of Olanzapine bulk offered by Cambrex Corporation

    Find a price of Ondansetron Hydrochloride bulk offered by Cambrex Corporation

    Find a price of Potassium P-Aminobenzoate bulk offered by Cambrex Corporation

    Find a price of Prazepam bulk offered by Cambrex Corporation

    Find a price of Ranolazine bulk offered by Cambrex Corporation

    Find a price of Remdesivir bulk offered by Cambrex Corporation

    Find a price of Remimazolam Besylate bulk offered by Cambrex Corporation

    Find a price of Ripretinib bulk offered by Cambrex Corporation

    Find a price of Rose Bengal bulk offered by Cambrex Corporation

    Find a price of Rotigotine bulk offered by Cambrex Corporation

    Find a price of Samidorphan bulk offered by Cambrex Corporation

    Find a price of Serdexmethylphenidate bulk offered by Cambrex Corporation

    Find a price of Sibofimloc bulk offered by Cambrex Corporation

    Find a price of Sodium Thiosulfate bulk offered by Cambrex Corporation

    Find a price of Sofosbuvir bulk offered by Cambrex Corporation

    Find a price of Sulfasalazine bulk offered by Cambrex Corporation

    Find a price of Terpin bulk offered by Cambrex Corporation

    Find a price of Tesofensine bulk offered by Cambrex Corporation

    Find a price of Tolterodine Tartrate bulk offered by Cambrex Corporation

    Find a price of Trilaciclib Dihydrochloride bulk offered by Cambrex Corporation

    Find a price of Voxelotor bulk offered by Cambrex Corporation

    Find a price of Zelnecirnon bulk offered by Cambrex Corporation

    Find a price of ZASOCITINIB bulk offered by Cambrex Corporation

    Find a price of UTENPANIUM CHLORIDE bulk offered by Cambrex Corporation

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search